Schedule 13G ownership disclosure

Dyne Therapeutics Inc

Security class unavailable · CUSIP: 26818M108

Event date: 2021-08-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,894,392
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000464
Form type
SC 13G
Filer
Dyne Therapeutics, Inc.
CIK
CIK 1818794
Filed
Aug 16, 2021
Reporting period
Aug 05, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub